description
The Global Health Centre invites you to join a webinar on how access to health products is being negotiated amidst the ongoing Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo (DRC), and the potential implications for the design of the Pathogen Access and Benefit Sharing (PABS) Annex.
Over the past several months, the BVD epidemic has grown faster than any previous Ebola outbreak, with cases having been detected in neighboring Uganda as well as Germany and France. WHO declared it a Public Health Emergency of International Concern (PHEIC) in May 2026. With no approved vaccines or therapeutics for BVD and limited diagnostics, ongoing efforts are focusing on assessing the potential of existing products approved for other strains of Ebola, and testing new candidates. As negotiations towards the PABS Annex are poised to resume, what do efforts to advance R&D and secure equitable access to products for BVD imply for the construction of a future PABS system?
The webinar will begin with an overview of developments on product R&D and access, followed by opportunities for questions and answers with representatives of relevant organizations.
Further information will follow closer to the date.
hosted by
